vs
Side-by-side financial comparison of TWIN DISC INC (TWIN) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
TWIN DISC INC is the larger business by last-quarter revenue ($90.2M vs $70.6M, roughly 1.3× Viridian Therapeutics, Inc.\DE). TWIN DISC INC runs the higher net margin — 24.8% vs -49.0%, a 73.8% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 0.3%). TWIN DISC INC produced more free cash flow last quarter ($1.2M vs $-84.7M).
Twin Disc, Inc. designs, manufactures, and distributes power transmission equipment for a wide range of applications, including marine, off-road vehicle, and industrial. The company was founded in 1918 to manufacture clutches for farm tractors. It is now a worldwide company with subsidiaries or sales offices in Asia, Europe, North America, Oceania, and South America.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
TWIN vs VRDN — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $90.2M | $70.6M |
| Net Profit | $22.4M | $-34.6M |
| Gross Margin | 24.8% | — |
| Operating Margin | 2.3% | -56.7% |
| Net Margin | 24.8% | -49.0% |
| Revenue YoY | 0.3% | 81958.1% |
| Net Profit YoY | 2334.3% | 54.9% |
| EPS (diluted) | $1.55 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $90.2M | — | ||
| Q3 25 | $80.0M | $70.6M | ||
| Q2 25 | $96.7M | — | ||
| Q1 25 | $81.2M | — | ||
| Q4 24 | $89.9M | — | ||
| Q3 24 | $72.9M | — | ||
| Q2 24 | $84.4M | — | ||
| Q1 24 | $74.2M | — |
| Q4 25 | $22.4M | — | ||
| Q3 25 | $-518.0K | $-34.6M | ||
| Q2 25 | $1.4M | — | ||
| Q1 25 | $-1.5M | — | ||
| Q4 24 | $919.0K | — | ||
| Q3 24 | $-2.8M | — | ||
| Q2 24 | $7.4M | — | ||
| Q1 24 | $3.8M | — |
| Q4 25 | 24.8% | — | ||
| Q3 25 | 28.7% | — | ||
| Q2 25 | 31.0% | — | ||
| Q1 25 | 26.7% | — | ||
| Q4 24 | 24.1% | — | ||
| Q3 24 | 26.5% | — | ||
| Q2 24 | 29.7% | — | ||
| Q1 24 | 28.2% | — |
| Q4 25 | 2.3% | — | ||
| Q3 25 | 2.8% | -56.7% | ||
| Q2 25 | 5.5% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | -0.2% | — | ||
| Q2 24 | 5.6% | — | ||
| Q1 24 | 4.9% | — |
| Q4 25 | 24.8% | — | ||
| Q3 25 | -0.6% | -49.0% | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | -1.8% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | -3.8% | — | ||
| Q2 24 | 8.8% | — | ||
| Q1 24 | 5.2% | — |
| Q4 25 | $1.55 | — | ||
| Q3 25 | $-0.04 | — | ||
| Q2 25 | $0.10 | — | ||
| Q1 25 | $-0.11 | — | ||
| Q4 24 | $0.07 | — | ||
| Q3 24 | $-0.20 | — | ||
| Q2 24 | $0.54 | — | ||
| Q1 24 | $0.27 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $490.9M |
| Total DebtLower is stronger | $44.5M | — |
| Stockholders' EquityBook value | $184.5M | $503.0M |
| Total Assets | $384.0M | $577.1M |
| Debt / EquityLower = less leverage | 0.24× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $490.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $44.5M | — | ||
| Q3 25 | $43.7M | — | ||
| Q2 25 | $31.4M | — | ||
| Q1 25 | $40.8M | — | ||
| Q4 24 | $24.9M | — | ||
| Q3 24 | $29.8M | — | ||
| Q2 24 | $25.8M | — | ||
| Q1 24 | $17.0M | — |
| Q4 25 | $184.5M | — | ||
| Q3 25 | $160.3M | $503.0M | ||
| Q2 25 | $164.0M | — | ||
| Q1 25 | $149.5M | — | ||
| Q4 24 | $147.0M | — | ||
| Q3 24 | $157.5M | — | ||
| Q2 24 | $154.7M | — | ||
| Q1 24 | $146.3M | — |
| Q4 25 | $384.0M | — | ||
| Q3 25 | $363.5M | $577.1M | ||
| Q2 25 | $355.6M | — | ||
| Q1 25 | $332.9M | — | ||
| Q4 24 | $307.4M | — | ||
| Q3 24 | $323.5M | — | ||
| Q2 24 | $312.1M | — | ||
| Q1 24 | $288.8M | — |
| Q4 25 | 0.24× | — | ||
| Q3 25 | 0.27× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.17× | — | ||
| Q3 24 | 0.19× | — | ||
| Q2 24 | 0.17× | — | ||
| Q1 24 | 0.12× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.6M | $-84.6M |
| Free Cash FlowOCF − Capex | $1.2M | $-84.7M |
| FCF MarginFCF / Revenue | 1.4% | -120.1% |
| Capex IntensityCapex / Revenue | 3.7% | 0.2% |
| Cash ConversionOCF / Net Profit | 0.20× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-70.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.6M | — | ||
| Q3 25 | $-7.5M | $-84.6M | ||
| Q2 25 | $16.4M | — | ||
| Q1 25 | $3.2M | — | ||
| Q4 24 | $8.7M | — | ||
| Q3 24 | $-4.3M | — | ||
| Q2 24 | $11.4M | — | ||
| Q1 24 | $6.2M | — |
| Q4 25 | $1.2M | — | ||
| Q3 25 | $-11.0M | $-84.7M | ||
| Q2 25 | $8.7M | — | ||
| Q1 25 | $906.0K | — | ||
| Q4 24 | $5.9M | — | ||
| Q3 24 | $-6.7M | — | ||
| Q2 24 | $10.3M | — | ||
| Q1 24 | $4.0M | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | -13.7% | -120.1% | ||
| Q2 25 | 9.0% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 6.5% | — | ||
| Q3 24 | -9.2% | — | ||
| Q2 24 | 12.2% | — | ||
| Q1 24 | 5.5% | — |
| Q4 25 | 3.7% | — | ||
| Q3 25 | 4.3% | 0.2% | ||
| Q2 25 | 8.0% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 2.9% | — |
| Q4 25 | 0.20× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.55× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 9.42× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.54× | — | ||
| Q1 24 | 1.63× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
